Pharmocotherapy Principles and Practice - Attention- Deficit Hyperactivity
Contact Hours: 0.5
ACPE No: 014-999-07-055-H04
Activity Type:
Release Date:
Expiration Date:
Learning Objectives
Upon completion of this activity the participant should be able to:
On completion of the chapter, the reader will be able to
1. Explain the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision criteria necessary for the diagnosis of attention-deficit hyperactivity disorder.
2. Recommend a therapeutic plan, including initial doses, dosage forms, and monitoring parameters, for a patient with attention-deficit hyperactivity disorder.
3. Differentiate between the available pharmacotherapy used for attention-deficit hyperactivity disorder with respect to pharmacology and pharmaceutical formulation.
4. Recommend second-line and/or adjunctive agents that can be effective alternatives in the treatment of attention-deficit hyperactivity disorder when stimulant therapy is less than adequate.
5. Address potential cost-benefit issues associated with pharmacotherapy of attention-deficit hyperactivity disorder.
6. Recommend strategies for minimizing adverse effects of attention-deficit hyperactivity disorder medications.
Faculty:
Computer Requirements for Online Courses
PC
- Windows 2000 SE or greater
- Flash Player Plugin 9.0 or later
- Internet Explorer 6.0 or later OR Firefox 2.0 or later
- Sound Card & Speakers
- 800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
- Adobe Acrobat Reader for viewing PDF's
MAC
- Mac OS 10.2.8
- Flash Player Plugin 9.0 or greater
- Safari 2.0 or above OR Firefox 2.0 or later
- Sound Card & Speakers
- 800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
- Adobe Acrobat Reader for viewing PDF's'
The University of Georgia College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.